Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 327 results for "kiran mazumdar shaw"

More focus on market share: Kiran Mazumdar-Shaw
Business Standard

More focus on market share: Kiran Mazumdar-Shaw

Interview with Chairman and managing director, Biocon Praveen Bose | Bengaluru May 1, 2015 Last Updated at 00:37 IST Biopharma major Biocon has reported a good set of numbers. Kiran Mazumdar-Shaw, chairman and managing director, explains the strategy for the ... Business Standard, 4 days ago
Money Today

Biocon can become a billion-dollar company by 2018: Kiran Mazumdar-Shaw

Biocon will focus on niche areas to reach its goal of becoming a billion-dollar player by 2018, Kiran Mazumdar-Shaw, chairperson and MD, Biocon, indicated in a conference call with the media on Thursday after announcing the company's fourth quarter ...
 Business Today India5 days ago Rationalising products to become specialised player: Biocon  Money Control5 days ago
Ani News

Kiran Mazumdar Shaw to head biotech association

The executive council of the Association of Biotechnology Led Enterprises has elected Dr Kiran Mazumdar Shaw, Chairman and Managing Director, Biocon, as its first non-executive chairman in an honorary capacity. Incidentally, Shaw also chairs ...
 Hindu Business Line4 weeks ago Kiran Mazumdar Shaw elected 1st non-executive chairman of ABLE  ZeeNews.com4 weeks ago Kiran Mazumdar Shaw Elected As Non-executive Chairman of ABLE  EHealth Magazine4 weeks ago Kiran Mazumdar Shaw elected as first non-executive chairman of ABLE, new EC formed  PharmaBiz4 weeks ago
[x]  

Is India Inc's new-found enthusiasm to have women board members a reflection of changing mindsets or mere tokenism?

Not just ticking the gender box By Kiran Mazumdar Shaw More than 250 companies appointed women directors on Wednesday to meet the Securities and Exchange Board of India's (Sebi) deadline to have at least one woman director on their boards by March ...
 Economic Times1 month ago Poke me: Is India Inc's new-found enthusiasm to have women board members a reflection of changing mindsets or mere tokenism?  Economic Times1 month ago
Money Control

Will get Syngene listed in FY16, to file DRHP in Q1: Biocon

Kiran Mazumdar Shaw, Chairperson and MD, Biocon also said that Syngene has good growth prospects and sound business plan and has a baseline valuation of Rs 3,800 crore.
 Money Control1 month ago Biocon Press Release on Q4 & FY 15 Results  APN News5 days ago Biocon top line grows 15% in Q4 FY15; Research Services delivers 27% growth; FY15 Revenues at Rs. 3143 Crore, PAT at Rs. 497 Crore  Businessworld India5 days ago Syngene International to enter capital market with equity issue of 22 mn shares  PharmaBiz6 days ago
[x]  
India Infoline

Biocon expects to list Syngene by July: Kiran Mazumdar Shaw

The company will give out the details of amount that will be raised after getting approval from SEBI and Foreign Investment Promotion Board. Biocon's subsidiary company, Syngene International filed a Draft Red Herring Prospectus with the Securities and ...
 India Infoline1 week ago IPO of Syngene should be possible by July: Kiran Mazumdar Shaw  India Infoline1 week ago
Jagran Post

Six Indians in Forbes's list of Asia's 50 Power Businesswomen

Six Indians, including State Bank of India chairman Arundhati Bhattacharyya and Biocon founder Kiran Mazumdar Shaw, figure in the Forbes's 2015 list of Asia's 50 Power Businesswomen showcasing a year of accomplishments by the region's female entrepreneurs and ...
 SME Times2 months ago Six Indians in Forbes 50 Asian power businesswomen list  Prokerala2 months ago Forbes presents the richest women in India  India Today1 month ago International Women's Day: India's super 6 achievers  Jagran Post1 month ago
[x]  

India's Biocon eyes an IPO for its in-house CRO

Biocon CEO Kiran Mazumdar-Shaw Indian biotech giant Biocon is planning to take Syngene, its in-house CRO, public in an IPO on the local exchange. As Business Standard reports, Biocon has filed to offer 22 million shares of Syngene, an 11% stake, ...
 Fierce CRO1 week ago Biocon's Syngene to build a plant in India  FiercePharmaManufacturing1 month ago

Prabha Kumar's family seeks public help to find her killer

SBS HINDI EXCLUSIVE WITH THE ONE AND ONLY KIRAN MAZUMDAR SHAW. One of India's most well known business tycoons, Kiran Mazumdar Shaw spoke exclusively to
 Special Broadcasting Service1 month ago Hundreds walk for Prabha despite bad weather  Special Broadcasting Service1 month ago MEET RAMAN BHALLA THE LIBERAL CANDIDATE FROM BLACKTOWN  Special Broadcasting Service1 month ago

Exceptional items pushes Biocon's net profit by over 78% in Q4

Biocon, a Rs. 3,050 crore plus leading innovation-led bio-pharmaceutical company, has posted satisfactory financial performance during the fourth quarter ended March 2014. Its consolidated net profit, after exceptional income of Rs. 105 crore on ...
 PharmaBiz1 day ago Biocon's net increases by 78%  Smart Investor4 days ago Biocon Q4 profit up 20% on Syngene stake sale  Hindu Business Line5 days ago Marico Q4 profit up 24% to Rs 110 crore  NewsR.in5 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - kiran mazumdar shaw
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less